Today: Dec 23, 2024

jab

EU delays approval of Novavax’s revised Covid jab

EU delays approval of Novavax’s revised Covid jab

Liberate the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favorite tales on this weekly e-newsletter.EU regulators have behind schedule a choice to approve Novavax’s variant-tailored Covid-19 vaccine, in
October 15, 2023